CBI.TA TLV
Clal Biotechnology Industries Ltd.
1W: +3.9%
1M: +4.8%
3M: -6.6%
YTD: -23.7%
1Y: -23.4%
3Y: -60.3%
5Y: -84.5%
₪24.20 ($0.08)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$68M
-57.3% ▼
5Y CAGR: -35.7%
Total Liabilities
$22M
-41.8% ▼
5Y CAGR: -29.0%
Shareholders Equity
$37M
-63.1% ▼
5Y CAGR: -30.4%
Cash & Investments
$5M
-62.5% ▼
5Y CAGR: -46.5%
Total Debt
$21M
-41.7% ▼
5Y CAGR: +0.9%
Net Debt
$17M
-43.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $68M | $53M | $7M | $6M | $4M |
| Short-Term Investments | $118M | $0 | $5M | $8M | $1M |
| Cash & ST Investments | $186M | $53M | $13M | $13M | $5M |
| Net Receivables | $11M | $9M | $4M | $512K | $505K |
| Inventory | $4M | $4M | $0 | $0 | $0 |
| Other Current Assets | $7M | $10M | -$3M | $0 | $0 |
| Total Current Assets | $211M | $78M | $17M | $15M | $6M |
| Property, Plant & Equip. | $15M | $18M | $5M | $5M | $2M |
| Goodwill & Intangibles | $241M | $216M | $0 | $0 | $0 |
| Long-Term Investments | $20M | $128M | $150M | $138M | $59M |
| Other Non-Current Assets | $127M | $133M | $11M | $745K | $1M |
| Total Non-Current Assets | $403M | $367M | $166M | $144M | $62M |
| Total Assets | $614M | $445M | $183M | $158M | $68M |
| — Liabilities — | |||||
| Accounts Payable | $10M | $15M | $0 | $0 | $0 |
| Short-Term Debt | $2M | $2M | $2M | $5M | $19M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $7M | $6M | -$1M | $619K | $279K |
| Total Current Liabilities | $28M | $36M | $3M | $7M | $20M |
| Long-Term Debt | $0 | $0 | $27M | $26M | $0 |
| Other Non-Current Liab. | $22M | $370K | $1K | $0 | $0 |
| Total Non-Current Liabilities | $72M | $71M | $35M | $30M | $2M |
| Total Liabilities | $100M | $107M | $38M | $37M | $22M |
| — Equity — | |||||
| Common Stock | $2M | $2M | $2M | $2M | $2M |
| Retained Earnings | -$1.1B | -$1.2B | -$1.3B | -$1.3B | -$1.4B |
| Accumulated OCI | $124M | $125M | $139M | $144M | $143M |
| Total Stockholders Equity | $306M | $173M | $126M | $99M | $37M |
| Total Liabilities & Equity | $614M | $445M | $183M | $158M | $68M |
| — Key Metrics — | |||||
| Total Debt | $8M | $12M | $37M | $36M | $21M |
| Net Debt | -$60M | -$41M | $2M | $30M | $17M |
| Total Investments | $139M | $128M | $156M | $146M | $60M |